PATRICK KELLY
Physician at 49 Pl, Gainesville, FL
License number
Florida 11507
Issued Date
May 30, 2007
Effective Date
Aug 22, 2011
Expiration Date
Jul 1, 2009
Category
Health Care
Type
Registration for Resident/HSE Physician
Address
Address
9188 SW 49Th Pl, Gainesville, FL 32608
Phone
(919) 949-6307
Organization information
See more information about PATRICK KELLY at bizstanding.comPatrick Kelly MD
1600 SW Archer Rd, Gainesville, FL 32603
Industry:
Internist
Phone:
(352) 265-0239 (Phone)
Patrick J. Kelly
Professional information
Process For Preparing Optical Fiber Cladding Solutions
US Patent:
5951920, Sep 14, 1999
Filed:
Jun 20, 1997
Appl. No.:
8/879639
Inventors:
Paul D. Schuman - Hawthorne FL
Raja Mani - Gainesville FL
Patrick Kelly - Gainesville FL
Raja Mani - Gainesville FL
Patrick Kelly - Gainesville FL
Assignee:
Optical Polymer Research, Inc. - Gainesville FL
International Classification:
F21V 900, G02B 600, G02B 602
US Classification:
252582
Abstract:
A process for preparing optical fiber cladding solutions starting with a monomer having the formula
CH. sub. 2. dbd. C(R)COOCHXY
where
R is H or methyl;
X is H or CF. sub. 3,
Y is H or CF. sub. 3 provided that when X is H, Y is --CF. sub. 3, --CF(CF. sub. 3)OCF. sub. 2 CF(CF. sub. 3)OC. sub. 4 F. sub. 9 or --(CF. sub. 2). sub. n Z,
Z is F or H; and
n is 1 to 8.
The monomers are subjected to UV light at about 1-400 nm for one to four hours until a cladding solution of desired viscosity is obtained.
Systems And Methods For Inhibiting Metastasis
US Patent:
2008026, Oct 23, 2008
Filed:
Aug 3, 2005
Appl. No.:
11/659555
Inventors:
Patrick J. Casey - Chapel Hill NC, US
Patrick Kelly - Gainesville FL, US
Timothy A. Fields - Durham NC, US
Patrick Kelly - Gainesville FL, US
Timothy A. Fields - Durham NC, US
International Classification:
A61K 31/7088, A61K 39/395, C12Q 1/02, A61P 35/04
US Classification:
4241301, 514 44, 435 29
Abstract:
The present invention relates to compositions and methods for cancer therapeutics. In particular, the present invention provides compositions and methods for inhibiting cancer metastasis by inhibiting G12 and G13 activity.